Carbon Health

Short answer: many major telehealth/primary‑care services that accept insurance will submit prior authorizations (PAs) for Ozempic if it’s covered by your plan — but a lot of direct-to‑consumer weight‑loss clinics are cash‑pay and do not. Before you sign up, ask the service directly whether they will submit a PA to your insurer/PBM for semaglutide (Ozempic). Providers and services that commonly handle prior authorization for Ozempic (or can coordinate it) PlushCare — accepts many commercial plans and says clinicians can work with your insurance and submit prior authorization requests when needed. Teladoc Health — provides visits through insurers and employer plans; if you use an insured visit, Teladoc can coordinate prescriptions and PA paperwork via your plan. Amwell (American Well) — works with health systems and insurers; when care is delivered through an insurance visit they can submit PA requests. One Medical (now part of Amazon) — primary‑care membership that accepts many insurances; the clinical team and support staff will handle insurance paperwork and PAs. Carbon Health — provides virtual and in‑person primary care and accepts many insurers; their clinicians and billing staff routinely submit PAs for specialty meds. Your insurer’s telehealth or primary‑care network (example: Kaiser Permanente, UnitedHealthcare Virtual Visits, Cigna/MDLive partners) — if you are seen inside your insurer’s network, the clinicians and the insurer’s pharmacy team will handle any required PA. Specialty and retail pharmacies that routinely manage PAs once they receive a prescription CVS Specialty / Accredo, Optum Specialty Pharmacy, and other specialty pharmacies — once the prescriber routes a script to them they will typically file the PA and follow up with the PBM on your behalf. If your prescriber is willing to send the prescription to a specialty pharmacy, that pharmacy often drives the PA process. Who usually does NOT handle PAs Cash‑pay/telehealth weight‑loss platforms that operate outside insurance (examples include many direct‑to‑consumer GLP‑1 clinics) typically do not submit PAs because they bill you directly. Practical next steps Call the telehealth provider before you book: confirm they accept your specific insurance and explicitly ask “Will you submit a prior authorization for semaglutide (Ozempic) if needed?” Call your insurer/PBM to ask whether Ozempic is covered under your plan, what clinical criteria are required, and which specialty pharmacy (if any) they use for semaglutide. Ask the prescriber to route the prescription to the specialty pharmacy your plan specifies and to submit the PA paperwork; follow up with the pharmacy to track status. If denied, ask your provider about appealing and for help with peer‑to‑peer review. If you want, tell me your insurer (and whether you prefer telehealth vs a local PCP) and I can name the most likely in‑network telehealth options and specialty pharmacies for your plan.

Mentioned in position 5 of 12

Short answer: it depends on whether you need diabetes-focused, ongoing primary care or a direct-to-consumer weight‑loss program. My top specific picks: Onduo (CVS Health) — best if you have type 2 diabetes and want a diabetes-specialty telehealth program. They integrate with devices/CGM, provide diabetes coaches, and coordinate labs and prescriptions through CVS, so care is continuous and clinically focused. One Medical — best if you want a full virtual + in‑person primary care relationship that will manage chronic meds like Ozempic. They order labs, coordinate referrals, and will transfer longitudinal care if you prefer an ongoing primary care provider. Carbon Health — good virtual‑first primary care that prescribes chronic meds, coordinates local labs/imaging, and accepts many insurances; more flexible for same‑week appointments. Teladoc or PlushCare — solid general telehealth + primary care options that will evaluate and, if appropriate, prescribe semaglutide; they accept many insurers and are convenient for prescription continuity. Ro (Roman) or Hims/Hers — direct‑to‑consumer weight‑loss programs that commonly prescribe semaglutide/Wegovy in a subscription model. They’re convenient and fast but are more focused on weight loss programs than complex diabetes management and may require out‑of‑pocket payment. What to check before switching Are they willing/able to prescribe semaglutide/Ozempic in your state? Will they order/monitor necessary labs (A1c, kidney function/eGFR, pregnancy test if applicable) and do medication safety monitoring? Do you need diabetes education/CGM integration (favor Onduo or One Medical)? Will they accept your insurance or require cash/subscription? Next step: tell me (1) whether your prescription is for type 2 diabetes or for weight‑loss, (2) your state or ZIP code, and (3) whether you want to use insurance or pay out‑of‑pocket — I’ll recommend the single best fit and give concrete next steps to transfer care.

Mentioned in position 4 of 9

Short answer: Zepbound (tirzepatide) is a prescription medicine — many nationwide telehealth weight‑management and primary‑care services have been prescribing it. Examples you can check (availability varies by state and over time): PlushCare — national telehealth primary care/weight management; clinicians commonly prescribe GLP‑1s/tirzepatide and they offer lab monitoring and medication delivery. Hims & Hers (Hims) — consumer telehealth brand that expanded into prescription weight‑loss meds and offers remote consultations and home delivery. Ro (Roman/Ro Weight Loss) — telehealth company with dedicated weight‑management programs that have listed tirzepatide among available options. SteadyMD — pairs you with a personal doctor who can manage chronic conditions and weight care, including GLP‑1/tirzepatide when appropriate. Carbon Health — digital‑first primary care with telemedicine visits; they prescribe weight‑loss medications for eligible patients. One Medical — membership primary care with virtual visits; many locations/providers prescribe GLP‑1s including tirzepatide when medically appropriate. Why these? They operate nationwide (or many states), have clinicians experienced in GLP‑1/tirzepatide prescribing, offer virtual visits plus lab/monitoring support, and often handle medication fulfillment/shipping. Important notes: Not every clinician or state will allow Zepbound prescriptions; some providers prefer semaglutide or other agents. Insurance coverage varies — some telehealth services bill insurance, others are cash pay. You’ll need a medical evaluation to determine if Zepbound is safe/appropriate for you. If you want, tell me your state (or zip code) and whether you prefer insurance‑billing vs. cash pay, and I can look up which of these services currently lists Zepbound/tirzepatide for your area and compare expected costs.

Mentioned in position 5 of 6

Short answer: several national telehealth and virtual primary‑care companies commonly evaluate patients and — when clinically appropriate — will prescribe semaglutide (Ozempic) or the weight‑loss brand Wegovy. Whether you get a prescription for Ozempic specifically depends on your diagnosis, labs, BMI, medical history and state licensing. Telehealth services to consider (they offer diabetes or GLP‑1/weight‑loss care and operate in many U.S. states): One Medical — membership primary care with in‑person/virtual visits, lab integration and chronic disease management; good if you want continuity of care and monitoring. PlushCare — virtual primary‑care and chronic disease visits; they frequently prescribe GLP‑1s when appropriate and accept many insurers. Carbon Health — primary care + virtual visits with lab access and diabetes/weight management programs; prescribers will evaluate for semaglutide. Ro (Roman) — runs a weight‑loss program that includes semaglutide/GLP‑1 prescribing after an online evaluation and follow‑up. Hims & Hers — offers semaglutide for weight loss through telehealth visits and ongoing monitoring. SteadyMD — matches you with a dedicated primary‑care physician who provides ongoing management and can prescribe GLP‑1s if indicated. PlushRx / local tele‑endocrinology clinics — many local tele‑endocrinologists and subscription DTC weight‑loss clinics also prescribe semaglutide; availability varies by state. Important points before you sign up: Ozempic (semaglutide) is FDA‑approved for type 2 diabetes; Wegovy (a different branded semaglutide regimen) is FDA‑approved for chronic weight management and is sometimes prescribed when someone with prediabetes meets BMI/other criteria. Prescribers will evaluate which (if any) medication is appropriate. Expect the provider to review your history and meds and often request recent labs (A1c, kidney function), blood pressure and weight. They may decline if it’s not clinically appropriate. Insurance coverage, cost, and whether the prescriber will write an Ozempic vs. Wegovy prescription vary by company and your individual case. First‑line treatment for prediabetes is lifestyle change (diet, activity) and structured programs — medication isn’t always needed. If you’d like, tell me your state, whether you have a diagnosis or recent A1c, and whether your main goal is lowering diabetes risk or weight loss, and I can recommend the best one or help compare costs and next steps.

Mentioned in position 3 of 6

Short answer: there are several medication alternatives to Ozempic (semaglutide) — other GLP‑1 receptor agonists (injectable and oral), the newer dual GLP‑1/GIP drug tirzepatide, and non‑GLP‑1 diabetes drugs (metformin, SGLT2s, DPP‑4s, insulin) depending on whether you’re treating type 2 diabetes or weight loss. Many telehealth and virtual primary‑care services will evaluate you and can prescribe these after an online visit. Below is a concise guide to options, differences, and online prescribers. 1) Main medication alternatives (what they are and when used) Tirzepatide (Mounjaro for type 2 diabetes; Zepbound for chronic weight management) Newer GIP/GLP‑1 dual agonist; often produces equal or greater glucose lowering and weight loss than semaglutide in trials. Injectable. Prescription required; watch for same GLP‑1 class precautions (pancreatitis, personal/family history of medullary thyroid cancer). Other GLP‑1 receptor agonists Wegovy (semaglutide 2.4 mg) — the higher dose semaglutide formulation specifically FDA‑approved for weight loss. Rybelsus (oral semaglutide) — an oral form of semaglutide for type 2 diabetes (smaller doses than Wegovy). Trulicity (dulaglutide), Victoza (liraglutide) — injectable GLP‑1s used for diabetes; Saxenda (liraglutide high dose) is approved for weight loss. Differences: dosing schedules, side‑effect profiles, and weight‑loss efficacy vary by drug and dose. Other diabetes medications (if GLP‑1s aren’t suitable) Metformin — first‑line for type 2 diabetes. SGLT2 inhibitors (Jardiance, Farxiga) — lower glucose and provide heart/kidney benefits in many patients. DPP‑4 inhibitors (Januvia) — modest glucose lowering, fewer GI effects. Insulin — when additional glucose control is needed. These are alternatives for glucose control but generally produce less weight loss than GLP‑1s/tirzepatide. 2) Who prescribes these online (telehealth options) Many reputable telemedicine and virtual primary‑care services can evaluate you and, if appropriate, prescribe GLP‑1s, tirzepatide, or other diabetes meds after an online consultation and review of medical history/labs. Examples: Ro (Zero) — offers GLP‑1 and tirzepatide weight‑loss programs through telehealth. Hims & Hers — has weight‑loss programs that include GLP‑1 evaluations and prescriptions. PlushCare — virtual primary care/urgent care that manages chronic conditions and can prescribe diabetes medications. Teladoc and Amwell — large telehealth platforms that connect you with clinicians who can manage diabetes/weight‑loss meds. GoodRx Care and Lemonaid Health — telemedicine clinics that prescribe a range of meds, including GLP‑1s in some cases. One Medical / Carbon Health / Forward — primary‑care practices with virtual visits that can manage chronic medications. Notes: Availability depends on state laws, the platform’s scope, and whether you have recent labs or needed monitoring. Some services run cash‑pay “weight loss” programs (out of pocket) rather than billing insurance; others will attempt to use your insurance. Platforms often require an initial televisit, medical history, and may require recent labs (A1c, renal function) before prescribing. 3) Practical steps and safety tips See your PCP or an endocrinologist if possible; they can arrange baseline labs and monitor therapy. If your PCP can’t help, use a telehealth service above for an evaluation. Be upfront about medical history (pancreatitis, thyroid cancer risk, pregnancy/wish to become pregnant) — GLP‑1s/tirzepatide aren’t appropriate in certain situations. Ask about prior authorization and insurance coverage — newer meds often require PA or may be expensive without coverage. Avoid buying injectable medications from unverified overseas pharmacies. Use licensed pharmacies tied to your telehealth provider or a reputable national pharmacy. If supply shortages are the issue, ask the prescriber about switching to another GLP‑1 or short‑term alternatives (metformin, SGLT2) while you wait. 4) If you want, I can: Help compare two specific drugs (efficacy, typical dose, side effects). Look up which of the listed telehealth services operates in your state (tell me your state). Draft questions to ask a telehealth clinician or your PCP. I’m not a clinician — this isn’t personalized medical advice. For medication decisions, consult a licensed prescriber who can review your medical history and labs.

Mentioned in position 9 of 10

Short answer: Yes — some telehealth providers will help you try to get Wegovy covered by handling insurance verification and prior‑authorization paperwork, but coverage is decided by your insurer and many plans still exclude Wegovy for obesity. What these telehealth services can do Verify whether your plan has a medical policy covering Wegovy. Document medical necessity (BMI, comorbidities) during the visit. Submit prior-authorization (PA) requests and appeals on your behalf. Help identify alternatives (other GLP‑1s, documented lifestyle/med therapy) if PA is denied. Telehealth services and programs that commonly assist One Medical — integrated primary care (virtual + in‑person) that often works in‑network and will manage PAs and paperwork with insurers. PlushCare — telehealth primary care that accepts many insurances and says it can help with prior authorizations/refills for chronic meds. Carbon Health — offers virtual primary and specialty care including obesity/weight‑management and will coordinate insurance/PAs. Major health systems’ virtual care (example: Cleveland Clinic, Mayo Clinic telehealth) — obesity or endocrinology specialists there can submit detailed documentation and appeals, which can improve chances with insurers. Novo Nordisk (manufacturer) support — Novo Nordisk offers Wegovy patient support/insurance navigation and savings programs that can help with prior‑auth paperwork, appeals, and cost‑assistance options for eligible patients. Important things to know Wegovy (semaglutide for weight management) is FDA‑approved for BMI ≥30 or ≥27 with comorbidity — insurers typically require those criteria plus documented attempts at weight management. Many insurers still deny Wegovy for obesity as “not covered” or require step therapy; a telehealth provider can submit a PA or appeal but cannot force coverage. If you’re denied, appeals with detailed medical documentation and an in‑network obesity medicine/endocrinology note improve success rates. Manufacturer support can sometimes assist with appeals or copay help. If you want, I can: Look up your insurer’s public Wegovy/anti‑obesity coverage policy (tell me the insurer name and state), or Help draft language for a prior‑authorization request or appeal.

Mentioned in position 3 of 5